Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with <i>EGFR</i> Gene Mutation–Case Report and a Literature Review

Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with <i>EGFR</i> Gene Mutation–Case Report and a Literature Review

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and the leading cause of cancer-related mortality worldwide. It is responsible for 80–85% of lung cancer cases. NSCLC can be divided into several groups, led by adenocarcinoma (ADC)–40–50% and squamous cell carcinoma (SCC)–20–...

Full description

Bibliographic Details
Main Authors: Anna Rekowska, Piotr Rola, Magdalena Wójcik-Superczyńska, Izabela Chmielewska, Paweł Krawczyk, Janusz Milanowski
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Current Oncology
Subjects:
osimertinib
squamous cell carcinoma
non-small cell lung cancer
EGFR
TKIs
Online Access:https://www.mdpi.com/1718-7729/29/5/285

Similar Items

Similar Items